Clinical Trials on HIV/HCV Coinfection in France

Total 2221 results

French National Agency for Research on AIDS and...
Tibotec Pharmaceutical Limited

Completed

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

HIV Infections

France
Gilead Sciences

Completed

TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada (TOTEM)

HIV Infections

France
Assistance Publique - Hôpitaux de Paris

Suspended

Bioequivalence Study of Didanosine in Children Treated for HIV (ddI)

HIV Infections

France
French National Agency for Research on AIDS and...

Completed

Long-Term Supervised Treatment Interruption in HIV-Infected Patients

HIV Infections

France
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

HIV Infections

France
French National Agency for Research on AIDS and...
Gilead Sciences; Abbott

Completed

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients (ANRS 140 DREAM)

HIV Infections

France
ANRS, Emerging Infectious Diseases
Abbott

Completed

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

HIV Infections

France
ANRS, Emerging Infectious Diseases

Completed

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults (TIPI)

HIV Infections

France
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

HIV Infections

France
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

HIV Infections

France
Gilead Sciences

Completed

Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial (COOL)

HIV Infections

France
French National Agency for Research on AIDS and...

Terminated

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

HIV Infections

France
Corinne Isnard Bagnis

Completed

Kidney Stone Risk Factors in Patients Infected With HIV (CALVIH)

Nephrolithiasis | HIV

France
Hôpital Européen Marseille

Unknown

Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP

Covid19 | Virus-HIV

France
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Does Micro-albuminuria is a Predictive Factor for Cognitive Impairment in Persons Living With HIV (PLHIV) Who Achieve cART-sustained Immunovirological Control ? (ALCOVE)

HIV

France
Centre Hospitalier Intercommunal de Toulon La Seyne...
Merck Sharp & Dohme LLC; Abbott

Completed

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients (IntensVIH)

HIV Infections

France
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC

Completed

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load (EASIER)

HIV Infections

France
French National Agency for Research on AIDS and...
Bristol-Myers Squibb; GlaxoSmithKline; Hoffmann-La Roche

Completed

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

HIV Infections

France
Assistance Publique - Hôpitaux de Paris

Completed

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics (Onto-Pgp)

HIV Infections

France
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC; Janssen-Cilag Tibotec

Completed

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses (ANRS139 TRIO)

HIV Infections

France
French National Agency for Research on AIDS and...
Aventis Pharmaceuticals

Completed

AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

HIV Infections

France
French National Agency for Research on AIDS and...
Aventis Pharmaceuticals

Terminated

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

HIV Infections

France
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

HIV Infections

France
French National Agency for Research on AIDS and...
Bristol-Myers Squibb; Gilead Sciences

Terminated

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

HIV Infections

France
ViiV Healthcare

Active, not recruiting

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF (EYEWITNESS)

HIV Infections | HIV

Netherlands, Germany, Mexico, Spain, United States, Belgium, Portugal, Canada, United Kingdom, Italy, Austria, France
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

HIV Infections | Hepatitis C

France, Spain, United States, Germany
French National Agency for Research on AIDS and...
Gilead Sciences; Roche Pharma AG

Completed

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients (HB01EMVIPEG)

HIV Infections | Hepatitis B

France
Tourcoing Hospital

Active, not recruiting

Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection. (CoroPrEP)

PREP

France
Pharmacia

Completed

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH) (PneumoVIH)

Pneumonia, Pneumococcal | Hiv

France
French National Agency for Research on AIDS and...
Gilead Sciences; Hoffmann-La Roche

Completed

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

HIV Infections | AIDS

France
Amgen

Completed

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection

Canada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
Clinique du Quartier Latin
Merck Frosst Canada Ltd.

Unknown

HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI Resistance

HIV Infections

Canada, Martinique
University Hospital, Clermont-Ferrand

Completed

DENTAL CARE OF PATIENTS LIVING WITH HIV (DENTA-VIH)

HIV Infections

France
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

HIV Infections | HIV Seronegativity

United States
Brigham and Women's Hospital
Weill Medical College of Cornell University; University of California, Davis; Florida International University and other collaborators

Completed

A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV

HIV/AIDS | Tuberculosis

Haiti
National Institute of Allergy and Infectious Diseases...

Completed

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

HIV Infections | Tuberculosis

Haiti
Tibotec Pharmaceuticals, Ireland

Completed

A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

HIV Infections | HIV-1

United States, France, Spain, Canada, South Africa, Argentina, Brazil, Romania
Groupe Hospitalier Paris Saint Joseph
Centre Hospitalier Victor Dupouy

Active, not recruiting

Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: (COVAP)

Covid19 | Nosocomial Pneumonia | Ventilator Associated Pneumonia

France
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement...

Recruiting

Mechanism of DCs Dysfunction in Chronic HBV Infection (HepatoDC)

HBV | NASH - Nonalcoholic Steatohepatitis

France
Association Clinique Thérapeutique Infantile du...

Recruiting

SARS-COV-2 Reinfection and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk: Matched Case-control Study (REPI)

Sars-CoV-2 Infection | MIS-C

France
Centre de Recherches et d'Etude sur la Pathologie...

Recruiting

Switch From Etravirine to Doravirine as a Part of Antiretroviral Combination (SWEED)

HIV Infections

France
Tourcoing Hospital

Completed

Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort (TOBIT)

HIV Infections

France
AbbVie

Completed

A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection (ENDURANCE-5 6)

Hepatitis C Virus (HCV)

United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
Centre de Recherches et d'Etude sur la Pathologie...
ViiV Healthcare; Institut de Sante Publique, d'Epidemiologie et de Developpement

Completed

Optimisation of Care in Vulnerable HIV Infected Individuals (OPTICARE)

HIV Infections

France
Hôpital Européen Marseille

Recruiting

Coronary Artery Disease (CAD) in Patients HIV-infected (CoroVIH)

HIV Infections

France
French National Agency for Research on AIDS and...

Completed

Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM) (DRAG)

HIV Infections

France
French National Agency for Research on AIDS and...
EuroVacc Foundation

Completed

Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers (EV03/ANRSVAC20)

HIV Infections

France, Switzerland
Centre Hospitalier Annecy Genevois

Recruiting

Aspects of Vulnerability of People Living With HIV in the Alpine Arc Region (ASPEGIC)

HIV Infections

France
Tourcoing Hospital

Active, not recruiting

Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) (coVIHd-19)

Covid19 | Virus-HIV

France

3

Subscribe